Lumos Pharma Inc (NAS:LUMO)
$ 3.94 0.1 (2.6%) Market Cap: 32.01 Mil Enterprise Value: 14.68 Mil PE Ratio: 0 PB Ratio: 3.10 GF Score: 47/100

Q4 2018 NewLink Genetics Corp Earnings Call Transcript

Feb 27, 2019 / 09:30PM GMT
Release Date Price: $15.03 (+1.21%)
Operator

Good day, ladies and gentlemen, and welcome to your NewLink Genetics Fourth Quarter 2018 Earnings Call. (Operator Instructions) As a reminder, today's conference will be recorded.

I would now like to turn the call over to Lisa Miller, Director of Investor Relations. You may begin.

Lisa Miller
NewLink Genetics Corporation - Director of IR

Thank you. I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information, concerning factors that could cause actual results to differ, is contained in our periodic reports filed with the SEC. The forward-looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements. Information presented on this call is contained in the earnings release we issued this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot